These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3855265)

  • 41. Long-term follow-up of a randomized post-induction therapy trial in acute myelogenous leukemia (a Southeastern Cancer Study Group trial).
    Volger WR; Weiner RS; Moore JO; Omura GA; Bartolucci AA; Stagg M
    Leukemia; 1995 Sep; 9(9):1456-60. PubMed ID: 7544851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of oral arsenic and all-trans-retinoic acid on coagulopathy in acute promyelocytic leukemia.
    Zhu HH; Guo ZP; Jia JS; Jiang Q; Jiang H; Huang XJ
    Leuk Res; 2018 Feb; 65():14-19. PubMed ID: 29232592
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemia.
    Eardley AM; Heller G; Warrell RP
    Leukemia; 1994 Jun; 8(6):934-9. PubMed ID: 8207987
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-dose cytosine arabinoside and daunorubicin as primary therapy in elderly patients with acute myelogenous leukemia. A phase I-II study of the Southeastern Cancer Study Group.
    Lazarus HM; Vogler WR; Burns CP; Winton EF
    Cancer; 1989 Mar; 63(6):1055-9. PubMed ID: 2917307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The continuous-DCMP therapy for acute nonlymphocytic leukemia in elderly patients--comparison with younger patients].
    Ito T; Yamamoto K; Kinoshita T; Sugiura I; Saito M; Ono Y; Hayashi K; Nagata K; Kamiya O; Ohara K
    Rinsho Ketsueki; 1989 Apr; 30(4):421-8. PubMed ID: 2769965
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute promyelocytic leukemia: impact of hemorrhagic complications on response to induction chemotherapy and survival.
    Humphries JE; Hess CE; Stewart FM
    South Med J; 1990 Oct; 83(10):1157-61. PubMed ID: 2218655
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Therapeutic results in acute myelogenous leukemia in the years from 1970 to 1982].
    Kurrle E; Hoelzer D; Heimpel H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):698-709. PubMed ID: 2416646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prognostic significance of leukemic cells clearance kinetics evaluation during the initial course of induction therapy with HAD (homoharringtonine, cytosine arabinoside, daunorubicin) in patients with de novo acute myeloid leukemia.
    Xiao Z; Xue H; Li R; Zhang L; Yu M; Hao Y
    Am J Hematol; 2008 Mar; 83(3):203-5. PubMed ID: 17874451
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995).
    Cassileth PA; Lee SJ; Litzow MR; Miller KB; Stadtmauer EA; Tallman MS; Lazarus HM; Bennett JM; Paietta E; Dewald GW; Rowe JM;
    Leuk Lymphoma; 2005 Jan; 46(1):55-61. PubMed ID: 15621781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Daunorubicin, cytosine arabinoside, 6-mercaptopurine riboside, and prednisolone (DCMP) combination chemotherapy for acute myelogenous leukemia in adults.
    Ohno R; Hirano M; Imai K; Koie K; Kamiya T; Nishiwaki H; Ishiguro J; Uetani T; Sako F; Imamura K
    Cancer; 1975 Dec; 36(6):1945-9. PubMed ID: 1060503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibrinolysis in patients with acute promyelocytic leukemia and disseminated intravascular coagulation during heparin therapy.
    Imaoka S; Ueda T; Shibata H; Masaoka T; Ogawa M; Sasaki Y; Iwanaga T; Terasawa T
    Cancer; 1986 Oct; 58(8):1736-8. PubMed ID: 2428461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic significance of myeloperoxidase containing blast cells in acute myelogenous leukaemia.
    Advani SH; Hegde UP; Iyer RS; Gopal R; Saikia TK; Pai SK; Nair CN; Kurkure PA; Pai VR; Nadkarni KS
    Indian J Med Res; 1993 Feb; 98():8-14. PubMed ID: 8388366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
    Escudier SM; Kantarjian HM; Estey EH
    Leuk Lymphoma; 1996 Feb; 20(5-6):435-9. PubMed ID: 8833399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia.
    Carey RW; Ribas-Mundo M; Ellison RR; Glidewell O; Lee ST; Cuttner J; Levy RN; Silver R; Blom J; Haurani F; Spurr CL; Harley JB; Kyle R; Moon JH; Eagan RT; Holland JH
    Cancer; 1975 Nov; 36(5):1560-6. PubMed ID: 1059499
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group.
    Amadori S; Testi AM; Aricò M; Comelli A; Giuliano M; Madon E; Masera G; Rondelli R; Zanesco L; Mandelli F
    J Clin Oncol; 1993 Jun; 11(6):1046-54. PubMed ID: 8501490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Successful treatment of subdural hematoma with operation in a patient with acute promyelocytic leukemia].
    Okubo C; Kanamori H; Sasaki S; Taguchi J; Otsuka M; Harano H; Ogawa K; Matsuzaki M; Mohri H; Okubo T
    Rinsho Ketsueki; 1997 Jun; 38(6):539-43. PubMed ID: 9248331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The combination of melphalan, cyclophosphamide and cytosine arabinoside as a conditioning regimen for autologous bone marrow transplantation for acute leukemia.
    Wang C; Qiao Z; Yang L; Ma L; Zhang H; Zhang J
    Chin Med J (Engl); 1996 Apr; 109(4):304-7. PubMed ID: 8758293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia.
    Liu J; Mi Y; Fu M; Yu W; Wang Y; Lin D; Bian S; Wang J
    Am J Hematol; 2009 Jul; 84(7):422-7. PubMed ID: 19484734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.
    Stone RM; Berg DT; George SL; Dodge RK; Paciucci PA; Schulman P; Lee EJ; Moore JO; Powell BL; Schiffer CA
    N Engl J Med; 1995 Jun; 332(25):1671-7. PubMed ID: 7760868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.